ProfileGDS5822 / ILMN_2785828
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 53% 5% 33% 17% 7% 60% 41% 8% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 123.153
GSM1276600PDAC Late Ablation Control 29.95
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 114.333
GSM1276603PDAC Late Ablation 21117
GSM1276604PDAC Late Ablation 36.97
GSM1303940PDAC Late Ablation_anti-CTLA4 128.460
GSM1303941PDAC Late Ablation_anti-CTLA4 219.841
GSM1303942PDAC Late Ablation_anti-CTLA4 35.68